‘Kalki 2’: Did you know Deepika Padukone had already shot for 20 days before exiting from the Prabhas starrer – Reports

Deepika Padukone’s departure from ‘Kalki 2898 AD 2’ has stirred controversy, despite reportedly filming for 20 days. Sources suggest a disagreement over a 25 percent remuneration hike led to her exit. Padukone indirectly addressed the situation with a post reflecting on her film ‘King’ with Shah Rukh Khan, emphasizing the importance of the filmmaking experience.

Read More

It’s Trump vs Trump: How US president’s trade rant undercut his own claim on India-Pak truce

Donald Trump’s recent criticism of India’s tariffs contradicts his earlier assertion that he influenced India to halt ‘Operation Sindoor’ against Pakistan by threatening trade restrictions. This outburst occurred amidst parliamentary debates in India, where PM Modi refuted Trump’s claim of mediation, attributing the cessation to the IAF’s successful strikes.

Read More

UAE: Dubai fines Dh152 million and deports 161 in one of the largest Residency Visa scams

Dubai’s Citizenship and Residency Court fined 161 individuals Dh152.24 million and ordered their deportation for illegally trading residency visas and shutting businesses without regularising employee status. This landmark ruling highlights the UAE’s strict stance against visa fraud. In a separate historic June case, 21 others were fined Dh25.2 million and convicted for a similar large-scale…

Read More

Maharashtra: Sharad Pawar urges govt to support farmers, expedite assessment of crop loss due to heavy rains

Sharad Pawar has pressed the Maharashtra government to promptly conduct panchnamas for crop and livestock losses due to heavy rains, especially in drought-prone regions like Solapur and Marathwada. He emphasized the need for swift assessment and disbursement of aid, covering both crop and farmland damage. Pawar also urged decisive action against cow vigilantes harassing farmers…

Read More

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26; hospitals, diagnostics segments to outperform

India’s pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry’s…

Read More